VentureWire -- Aiming to launch its renewable fuels and chemicals business in 2011, synthetic biology company Amyris Biotechnologies Inc. has raised $24.7 million of a potential $62 million Series C funding round.
VentureWire -- Aiming to launch its renewable fuels and chemicals business in 2011, synthetic biology company Amyris Biotechnologies Inc. has raised $24.7 million of a potential $62 million Series C funding round.
